Munich Re : Close to major technical levels
Entry price | Target | Stop-loss | Potential |
---|
€201.3 |
€193 |
€204.5 |
+4.12% |
---|
Muenchener Rueckversicherung shares are trading in close proximity to a major resistance zone estabished around 203.1 EUR on the weekly chart. The potential for additional upside seems limited, which suggests that short positions can be opened at this time.
Summary● The company usually posts poor financials for mid or long term investments.
Strengths● The company's attractive earnings multiples are brought to light by a P/E ratio at 10.82 for the current year.
● The company is one of the best yield companies with high dividend expectations.
● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
● The stock is in a well-established, long-term rising trend above the technical support level at 189.65 EUR
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at EUR 203.1.
● The stock is close to a major daily resistance at EUR 201.8, which should be gotten rid of so as to gain new appreciation potential.
● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.